Association of serum vitamin D levels and transient tachypnea of newborn: a case control study
Keywords:Lower segment cesarean section (LSCS), Respiratory distress, Term newborns, Transient tachypnea of newborn (TTN), Vitamin D
Background: Transient tachypnea of newborn (TTN) is a common cause of respiratory distress in newborns with estimated incidence of 1-2% of all newborns. Although a self-limiting transient condition but it may cause severe morbidities. This study was conducted to find association of serum vitamin D levels in neonates who develop TTN as compared to normal healthy neonates.
Methods: With thorough history with structured questionnaire and lab tests, serum vitamin D levels of 45 neonates who develop TTN were compared with 56 healthy neonates in control group.
Results: Out of 45 neonates who develop TTN 39(86.7%) were deficient in vitamin D as compared to control group where 33(58.9%) out of 56 healthy neonates were deficient in vitamin D.
Conclusions: Lower vitamin D levels at birth in term neonates is associated with increased risk of developing TTN and vitamin D may have a role in its pathogenesis.
Kumar A, Bhat BV. Epidemiology of respiratory distress of newborns. Indian J Pediatr. 1996;63:93-8.
Kotecha S, Allen J. Oxygen therapy for infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2002;87:F11-F14
Shaw NJ, Kotecha S. Management of infants with chronic lung disease of prematurity in the United Kingdom. Early Hum Dev. 2005;81:165-70.
Hibbard J, Wilkins I, Sun L, Gregory K, Haberman S, Hoffman M et al. Respiratory morbidity in late preterm births. JAMA. 2010;304:419-25.
Qandalji B. Full term neonatal admissions. Early Human Development Conference: 2nd Union of European Neonatal and Perinatal Societies, UENPS Congress Academic Olympics Istanbul Turkey Conference Start 2010;86(pp S133):S133.
Li-ling Q, Cui-qing L, Yun-xia G, Ye-jun J, Li-ming N, Shi-wen X et al. Current status of neonatal acute respiratory disorders: a one-year prospective survey from a Chinese neonatal network. Chinese Medic J. 2010;123:2769-75.
Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician. 2007;76(7):987-94.
Avery ME, Gatewood OB, Brumley G. Transient tachypnea of newborn: possible delayed resorption of Fluid at Birth. Am J Dis Child. 1966;111:380-5.
Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol. 1995;102:101-6.
Liem JJ, Huq SI, Ekuma O, Becker AB, Kozyrskyj AL. Transient tachypnea of the newborn may be an early clinical manifestation of wheezing symptoms. J Pediatr. 2007;151:29-33.
Keleş E, Gebeşçe A, Demirdöven M, Yazgan H, Baştürk B, Tonbul A. The effects of inhaled β-adrenergic agonists in transient tachypnea of the newborn. Global Pediatr Health. 2016;3:2333794X16645258.
Helve O, Janer C, Pitkanen O, Andersson S: Expression of the epithelial sodium channel in airway epithelium of newborn infants de-pends on gestational age. Pediatr. 2007;120:1311-6.
Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol. 2006;30:34-43.
Aathi MK. Transient tachypnea of newborn (TTN): An overview. Int J Nur Edu Res. 2014;2(2):99-103.
Esposito S, Lelii M. Vitamin D and respiratory tract infections in childhood. BMC Infectious Diseases. 2015;15:487.
Narang G, Arora S, Kukreja S, Shifali. Association of vitamin D deficiency with acute lower respiratory infection in toddlers. J Nepal Paediatr Soc. 2016;36(1):14-18.
Marin L, Dufour ME, Nguyen TM, Tordet C, Garabedian M. Maturational changes induced by 1α,25-dihydroxyvitamin D 3 in type II cells from fetal rat lung explants. Am J Physiol. 1993;265:45-52.
Marin L, Dufour ME, Tordet C, Nguyen M: 1,25(OH)2D3 stimulates phospholipid biosynthesis and surfactant release in fetal rat lung explants. Biol Neonate. 1990;57:257-60.
Dani C, Reali MF, Bertini G, Wiechmann L, Spagnolo A, Tangucci M, Rubaltelli FF. Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology. Eur Respir J. 1999;14:155-9.
Bodnar LM, Catov JM, Simhan HN, Holick MA. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92(9):3517-22.
Holok MF. Vitamin D status: measurement, interpretation and clinical application. Ann Epidemiol. 2009;38:1361-9.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, HeanZey RP et al. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.
Misawa Y, Baba A, Ito S, Tanaka M, Shiohara M. Vitamin D3 induces expression of human cathelicidin antimicrobial peptide 18 in newborns. Int J Hematol. 2009;90(5):561-70.
Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009;65(5):106-13.
Pfeffer PE, Hawrylowicz CM. Vitamin D and lung disease. Thorax 2012;67:1018-20.
Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-κB-linked chemokines and cyto-kines in airway epithelium while maintaining the antiviral state. J Immunol 2010;184:965-74.
Banerjee A, Panettieri R Jr. Vitamin D modulates airway smooth muscle function in COPD. Curr Opin Pharmacol. 2012;12:266-74.
Khoo AL, Chai L, Koenen H, Joosten I, Netea M, van der Ven A: Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol. 2012;38:122-35.
Hoyer-Hansen M, Nordbrandt SP, Jaattela M: Autophagy as a basis for the health-promoting effects of vitamin D. Trends Mol Med. 2010;16:295-302.
Konca C, Kahramaner Z, Bulbul M, Erdemir A. Association between Serum 25-Hydroxyvitamin D Levels and TTN. Horm Res Paeditrc.2014;81:397-401.
Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88:582-6.
Cadario F, Savastio S, Pozzi E, Capelli A, Don-di E, Gatto M et al. Vitamin D status in cord blood and newborns: ethnic differences. Ital J Pediatr. 2013;39:35.